Fishy Whales
Security

ALNY · Alnylam Pharmaceuticals Inc

40 institutional holder(s) · 5 congressional trade(s)
← Funds
Alnylam Pharmaceuticals Inc is a company in the Health Care sector, identified from SEC filings. It is held by 12 of 26 tracked funds in the latest quarter and traded by 3 members of Congress in disclosed filings.

Institutional holders

13F
FundValueShares
Vanguard Group $4.93B12,397,073
Fidelity $3.11B10,325,076
BlackRock $1.26B4,171,597
State Street $1.07B3,555,689
BlackRock $1.03B3,428,111
Fidelity $716.6M2,380,552
Geode Capital Management $686.9M2,288,725
Two Sigma Investments $564.7M1,875,937
Fidelity $438.7M1,457,197
Vanguard Group $327.6M823,784
BlackRock $300.9M999,406
Fidelity $227.6M756,165
Bank of America $176.4M586,016
BlackRock $128.4M426,523
Geode Capital Management $104.5M347,115
BlackRock $102.8M341,519
Millennium Management $95.1M316,001
Morgan Stanley $92.7M308,083
BlackRock $91.4M303,580
Morgan Stanley $84.3M280,185
Vanguard Group $82.4M207,271
BlackRock $69.5M230,932
Bank of America $60.6M201,304
Morgan Stanley $54.9M182,488
Citadel Advisors $53.5M177,597
BlackRock $50.4M167,576
BlackRock $44.9M149,228
Bank of America $42.3M140,417
BlackRock $41.8M138,832
Morgan Stanley $41.3M137,251
BlackRock $35.4M117,758
BlackRock $35.1M116,696
BlackRock $32.7M108,675
Fidelity $30.9M102,664
Bridgewater Associates $30M99,584
BlackRock $27.7M91,954
Vanguard Group $25.7M64,553
Citadel Advisors $24.6M81,600
Vanguard Group $24.4M61,251
Bank of America $22.5M18,750,000

Congressional trades

STOCK Act
MemberTypeDate
Jefferson Shreve sell 05/12/2025
Josh Gottheimer sell 01/29/2024
Josh Gottheimer buy 01/11/2024
Josh Gottheimer buy 09/28/2022
Richard L. Hanna buy 10/13/2016